William J Garner's Net Worth
$503 Thousand
Who is William J Garner?
William J Garner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Urigen Pharmaceuticals, Inc., DelMar Pharmaceuticals, Inc., and InMed Pharmaceuticals Inc..
SEC CIK
William J Garner's CIK is 0001407235
Past Insider Trading and Trends
2009 was William J Garner's most active year for acquiring shares with 15 total transactions. William J Garner's most active month to acquire stocks was the month of December. 2014 was William J Garner's most active year for disposing of shares, totalling 5 transactions. William J Garner's most active month to dispose stocks was the month of February. 2015 saw William J Garner paying a total of $10,016.27 for 33,332 shares, this is the most they've acquired in one year. In 2014 William J Garner cashed out on 80,000 shares for a total of $104,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Urigen Pharmaceuticals, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.01% | 1K |
$0.09 | $90.00 | 18.59M |
Mar 13
| |||
Form 4
| +0.01% | 1K |
$0.09 | $90.00 | 18.59M |
Mar 13
| |||
Form 4
| +0.01% | 1K |
$0.09 | $90.00 | 18.59M |
Mar 11
| |||
Form 4
| +0.03% | 5K |
$0.08 | $400.00 | 18.58M |
Mar 5
| |||
Form 4
| +0.01% | 1K |
$0.10 | $100.00 | 18.58M |
Feb 25
| |||
Form 4
| +0.18% | 33.8K |
$0.14 | $4,792.00 | 18.58M |
Jan 29 - Jan 30
| |||
Form 4
| +0.08% | 15K |
$0.14 | $2,050.00 | 18.54M |
Jan 26 - Jan 27
| |||
Form 4/A
| +0.26% | 48K |
$0.10 | $4,750.00 | 18.53M |
Jan 21
| |||
Form 4
| +0.26% | 48K |
$0.05 | $2,160.00 | 18.53M |
Jan 21
| |||
Form 4
| +0.03% | 5K |
$0.05 | $225.00 | 18.48M |
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DelMar Pharmaceuticals, Inc. (KTRA) Snapshot price: $0.1775
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.69% | 16.67K |
$0.60 | $9,999.60 | 2.42M |
Jul 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +23,885.41% | 2.39M |
—
|
—
| 2.4M |
Oct 28
| |||
Form 4
|
—
|
0
|
$1.30 | -$104,000.00 | 10K |
Mar 18
| |||
Form 4
| +100.00% | 5K |
—
|
—
| 10K |
Nov 26
| |||
Form 4
|
∞
| 5K |
$1.00 | $5,000.00 | 5K |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
InMed Pharmaceuticals Inc. (INM) Snapshot price: $0.2718
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||